Skip Navigation

This Article
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to My Personal Archive
Right arrow Download to citation manager
Right arrowRequest Permissions
Right arrow Disclaimer
Google Scholar
Right arrow Articles by Levin, J H
Right arrow Articles by Clarke, P D
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Levin, J H
Right arrow Articles by Clarke, P D
Social Bookmarking
 Add to CiteULike   Add to Connotea   Add to Del.icio.us  
What's this?

British Medical Bulletin 49:326-347 (1993)
© 1993 The British Council


research-article

Travel vaccines—a review of current thinking

J H Levin and P D Clarke

Medical Advisory Services for Travellers Abroad (MASTA), London School of Hygiene and Tropical Medicine London, UK

Abstract

More controversial aspects of the administration of vaccines are discussed with particular emphasis on the uncertainties surrounding measurement and significance of immunological markers in predicting efficacy. New areas of vaccine development are highlighted, particularly the importance of greater understanding of the gut immune mechanisms which promise oral delivery routes for a variety of immunogens. Emphasis is laid on the requirement for expert administration of intradermal injection if protection is to be reliable. Several new vaccines have been introduced recently and relevant issues relating to typhoid, cholera and hepatitis A vaccines are discussed. New possibilities for immunisation against travellers diarrhoea are appraised. The required frequency of booster doses is discussed for several vaccines where it is found that long term protection has often not been well researched. This is nowhere better demonstrated than with hepatitis B. Finally less commonly used vaccines are discussed and the importance of assessing true risk before deciding on use is emphasized.


Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us    What's this?




Disclaimer: Please note that abstracts for content published before 1996 were created through digital scanning and may therefore not exactly replicate the text of the original print issues. All efforts have been made to ensure accuracy, but the Publisher will not be held responsible for any remaining inaccuracies. If you require any further clarification, please contact our Customer Services Department.